ResMed Inc.RMDNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank36
3Y CAGR-14.9%
5Y CAGR-8.1%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-14.9%/yr
vs +14.2%/yr prior
5Y CAGR
-8.1%/yr
Recent deceleration
Acceleration
-29.1pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 7.73% |
| 2024 | 6.91% |
| 2023 | 13.43% |
| 2022 | 12.56% |
| 2021 | 11.56% |
| 2020 | 11.79% |
| 2019 | 16.44% |
| 2018 | 7.39% |
| 2017 | 21.76% |
| 2016 | 3.30% |